These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25466963)

  • 1. Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.
    Sasaki M; Nitta T; Sato Y; Nakanuma Y
    Hum Pathol; 2015 Feb; 46(2):202-9. PubMed ID: 25466963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic characterization of precursors and cholangiocarcinoma referring to peribiliary capillary plexus: a new pathologic approach to bile duct neoplasm.
    Nakanuma Y; Kakuda Y; Canh HN; Sasaki M; Harada K; Sugino T
    Virchows Arch; 2024 Aug; 485(2):257-268. PubMed ID: 39008118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
    PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
    Zen Y; Britton D; Mitra V; Pike I; Sarker D; Itoh T; Heaton N; Quaglia A
    Histopathology; 2014 Dec; 65(6):784-92. PubMed ID: 25039376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of pediatric biliary intraepithelial neoplasia diagnosed from a choledochal cyst specimen.
    Gang S; Kwon H; Song IH; Namgoong JM
    World J Surg Oncol; 2024 Apr; 22(1):105. PubMed ID: 38643155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry analysis of autophagy-related proteins Beclin-1, p62/SQSTM1, and LC3B in breast carcinoma progression to bone metastasis.
    Maroni P; Lombardi G; Ferraretto A; Bendinelli P
    Pathol Res Pract; 2024 Aug; 260():155414. PubMed ID: 38901141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic cholangiocarcinoma with extensive intraductal extension of high-grade biliary intraepithelial neoplasia: a case report.
    Kubota H; Hashimoto Y; Toyota K; Yano R; Kobayashi H; Yokoyama Y; Sakashita Y; Taniyama K; Miyamoto K; Murakami Y
    Surg Case Rep; 2023 Sep; 9(1):164. PubMed ID: 37721561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary neoplasm of the bile duct with metachronous development in the downstream bile duct after radical resection.
    Ito T; Hisa T; Ito Y; Kudo A; Yamada T; Osera S; Tomori A; Fukushima H; Aoyagi D; Shiozawa S
    Clin J Gastroenterol; 2024 Feb; 17(1):155-163. PubMed ID: 37837506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INTRAHEPATIC BILIARY PROLIFERATIONS: HISTOPATHOLOGY AND POTENTIAL IMMUNOHISTOCHEMICAL MARKERS.
    Hirayama AB; Mello ES; Alves VAF
    Arq Gastroenterol; 2023; 60(3):393-403. PubMed ID: 37792770
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arid1a mutation suppresses TGF-β signaling and induces cholangiocarcinoma.
    Guo B; Friedland SC; Alexander W; Myers JA; Wang W; O'Dell MR; Getman M; Whitney-Miller CL; Agostini-Vulaj D; Huber AR; Mello SS; Vertino PM; Land HK; Steiner LA; Hezel AF
    Cell Rep; 2022 Aug; 40(9):111253. PubMed ID: 36044839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage.
    Fukushima NM; Adachi T; Tanaka T; Matsushima H; Imamura H; Hara T; Soyama A; Hidaka M; Kanetaka K; Eguchi S
    Anticancer Res; 2024 Jun; 44(6):2417-2424. PubMed ID: 38821583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
    Kim H; Hwang H; Lee H; Hong HJ
    Mol Cells; 2017 May; 40(5):363-370. PubMed ID: 28535665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COTE1 Facilitates Intrahepatic Cholangiocarcinoma Progression via Beclin1-Dependent Autophagy Inhibition.
    Zhang H; Chen S; Xu S; Li X
    Biomed Res Int; 2023; 2023():5491682. PubMed ID: 37780485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
    Schläfli AM; Adams O; Galván JA; Gugger M; Savic S; Bubendorf L; Schmid RA; Becker KF; Tschan MP; Langer R; Berezowska S
    Oncotarget; 2016 Jun; 7(26):39544-39555. PubMed ID: 27250032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.
    Sirica AE; Gores GJ
    Hepatology; 2014 Jun; 59(6):2397-402. PubMed ID: 24123296
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of RNF213 as a Potential Suppressor of Local Invasion in Intrahepatic Cholangiocarcinoma.
    Chiablaem K; Jinawath A; Nuanpirom J; Arora JK; Nasaree S; Thanomchard T; Singhto N; Chittavanich P; Suktitipat B; Charoensawan V; Chairoungdua A; Jinn-Chyuan Sheu J; Kiyotani K; Svasti J; Nakamura Y; Jinawath N
    Lab Invest; 2024 Jul; 104(7):102074. PubMed ID: 38723854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
    Martin-Serrano MA; Kepecs B; Torres-Martin M; Bramel ER; Haber PK; Merritt E; Rialdi A; Param NJ; Maeda M; Lindblad KE; Carter JK; Barcena-Varela M; Mazzaferro V; Schwartz M; Affo S; Schwabe RF; Villanueva A; Guccione E; Friedman SL; Lujambio A; Tocheva A; Llovet JM; Thung SN; Tsankov AM; Sia D
    Gut; 2023 Apr; 72(4):736-748. PubMed ID: 35584893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms.
    Gonzalez-Mancera MS; Siref A; Kosari K; Nissen N; Gaddam S; Hendifar A; Osipov A; Waters K; Hutchings D; Guindi M; Larson BK
    Am J Clin Pathol; 2024 Jul; 162(1):41-50. PubMed ID: 38345293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma.
    Zhang M; Huang Y; Pan J; Sang C; Lin Y; Dong L; Shen X; Wu Y; Song G; Ji S; Liu F; Wang M; Zheng Y; Zhang S; Wang Z; Ren J; Gao D; Zhou J; Fan J; Wei W; Lin J; Gao Q
    Cancer Discov; 2023 Oct; 13(10):2248-2269. PubMed ID: 37486241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.